METFORMIN HYDROCHLORIDE (metformin) by Viatris (2) is 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Approved for type 2 diabetes mellitus. First approved in 2012.
Drug data last refreshed 18h ago
2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. With metformin therapy, insulin secretion…
Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets
Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets
Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets
A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)
Worked on METFORMIN HYDROCHLORIDE at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.